首页> 外国专利> Critical hypoxia-inducible factor-1alpha residues, products and methods related thereto

Critical hypoxia-inducible factor-1alpha residues, products and methods related thereto

机译:关键的缺氧诱导因子-1α残基,与其相关的产品和方法

摘要

A modified HIF-1alpha protein is capable of avoiding degradation by failing to bind or failing to bind properly to pVHL. This modified HIF-1alpha protein can be used in research regarding hypoxic response as well as in treatments for hypoxic-related conditions. The amino acids at residues 568, 570, 571, and 573 of HIF-1alpha play a critical role in mediating degradation at normoxia. Further, the pairs of residues at 560 and 561, and at 566 and 567 are critical as well. Resistance to pVHL-mediated degradation can be imparted using specific alterations at these residues. Active fragments of the HIF-1alpha N-TAD may also be used as treatments for hypoxic-related conditions.
机译:修饰的HIF-1α蛋白能够通过不与pVHL结合或不与pVHL正确结合而避免降解。这种修饰的HIF-1alpha蛋白可用于有关低氧反应的研究以及用于低氧相关疾病的治疗。 HIF-1alpha残基568、570、571和573处的氨基酸在介导常氧性降解中起关键作用。此外,在560和561以及在566和567处的残基对也是关键的。可以使用这些残基的特定改变来赋予对pVHL介导的降解的抗性。 HIF-1αN-TAD的活性片段也可用作缺氧相关疾病的治疗方法。

著录项

  • 公开/公告号AU2003208684A8

    专利类型

  • 公开/公告日2003-09-16

    原文格式PDF

  • 申请/专利权人 ANGIOGENETICS SWEDEN AB;

    申请/专利号AU20030208684

  • 申请日2003-03-05

  • 分类号C07K14/47;A61P3/00;A61P9/10;A61K38/17;A61P29/00;

  • 国家 AU

  • 入库时间 2022-08-21 23:57:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号